The sale sizes are too small relative to market cap to be informative, treat as routine insider liquidity. No CEO/CFO selling and no buying signals present. Monitor the next QURE catalyst (pipeline updates for AMT-130 / Huntington's gene therapy) as the real driver; insider activity alone does not warrant action here.
QURE drugs
QURE drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 15 $27.87entry
- T+1 · 5mo ago −3.16%α −2.56% · $26.99
- T+5 · 5mo ago +59.28%α +60.66% · $44.39
- T+20 · 4mo ago +47.47%α +48.22% · $41.10
- T+60 · 2mo ago +65.05%α +64.05% · $46.00
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two directors sold a combined ~$148K in QURE stock over the past week, with the larger June 11 cluster showing 6 directors plus the Chief Customer Officer selling a total of ~$775K at $27.06, nearly all sales are small, pre-planned-looking dispositions in the 1.9K–2.7K share range. These sales represent ~0.05% of market cap, which is trivial and routine. The broader 7-day insider-trade picture is overwhelmingly SELL-side with no material open-market buying, but the dollar amounts are miniscule for a $1.7B biotech and likely reflect periodic stock-vesting / 10b5-1-generated sales, not a coordinated bearish signal.
Key Financial Metrics
Key Facts
- Insider cluster over 7 days: Chief Customer & Strategy Officer + 6 directors sold on June 11 at $27.06, total ~$775K
- June 10 director grants (13,980 shares each to multiple directors at $0) were non-cash awards, no economic signal
- All individual sales are in the $50K–$430K range; combined ~$775K is ~0.05% of $1.7B market cap
- No C-suite CEO, CFO, or COO participated in the sales, mostly Director-level disposals
- Multiple Directors simultaneously exercised options (Gut Robert: M-exercise + same-day S-sale at $26.07) consistent with cashless exercise / tax-motivated sale pattern
Financial Impact
Total insider open-market sales of ~$148K (smaller cluster) + ~$775K (June 11 cluster) = ~$923K combined, or ~0.054% of $1.7B market cap
Risk Factors
- If a larger C-suite sale emerges in the next filing window, the pattern could shift from routine to concerning
- Gene therapy clinical trial setbacks or regulatory delays remain the primary fundamental risk for QURE, insider trading does not speak to this
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-QURE-1781301885155 |
Track record
38 reports on QURE
6 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +27.15% at T+20 after the Jul 29, 2026 report. 8 of 11 went positive at some point.
Filters
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $22.79 to $22.71 Now $21.88 −3.99% ▼ −0.35% +0.02% vs SPY
- Nov 4, 202612d ago 8-K Bullish 7/10 No price data
- Nov 4, 202612d ago Press Release Neutral 6/10 Entry $23.03 to $21.01 Now $21.88 −4.99% ▼ −8.77% −4.36% vs SPY
- Nov 2, 202614d ago 8-K Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
- Nov 2, 202614d ago Press Release Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
- Oct 16, 20264w ago SC 13G/A Neutral 3/10 Entry $21.78 to $22.20 Now $21.88 +0.46% ▲ +1.93% +1.51% vs SPY
- Sep 2, 202610w ago 8-K Bullish 7/10 Entry $46.23 to $44.86 Now $21.88 −52.67% ▼ −2.96% −4.01% vs SPY
- Jul 29, 202615w ago 8-K Bullish 8/10 Entry $40.07 to $42.19 Now $21.88 −45.40% ▲ +5.29% +3.61% vs SPY
- Jul 7, 202619w ago Insider Cluster Bearish 5/10 Entry $41.41 to $43.49 Now $21.88 +47.16% ▼ −5.02% −5.33% vs SPY
- Jul 2, 202619w ago Insider Cluster Bearish 4/10 Entry $41.81 to $41.36 Now $21.88 +47.67% ▲ +1.08% +1.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers